Sign in

CIK 0001585364 · Large accelerated filer

PERRIGO Co plc

Sign in to watch
Ticker
PRGO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
operating
Phone
269-673-8451
Business address
THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
Former names
PERRIGO Co Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Option exercise EVP, Chief Medical Officer acquired 4,008 shares (option exercise)
  9. 4 Option exercise EVP & CHRO acquired 3,922 shares (option exercise)
  10. 4 Option exercise EVP, Gbl Ops & SC & CTO acquired 5,242 shares (option exercise)
  11. 4 Option exercise EVP & General Counsel acquired 3,518 shares (option exercise)
  12. 4 Option exercise EVP and CIO acquired 1,881 shares (option exercise)
  13. 4 Option exercise EVP & Chief Financial Officer acquired 4,870 shares (option exercise)
  14. 4 Option exercise EVP & Chief Scientific Officer acquired 3,776 shares (option exercise)
  15. 4 Option exercise EVP & President CHCI acquired 9,256 shares (option exercise)
  16. 4 Open-market buy EVP & Chief Scientific Officer bought 2,490 shares at $27.26 ($67,877)
  17. 4 Open-market buy EVP & Chief Scientific Officer bought 1,545 shares at $26.44 ($40,850)
  18. 4/A Open-market buy EVP & Chief Scientific Officer bought 2,040 shares at $29.34 ($59,854)
  19. 4 Grant or award EVP, Gbl Ops & SC & CTO acquired 11,806 shares (grant or award)
  20. 4 Grant or award EVP & CHRO acquired 7,291 shares (grant or award)

Page 8 of 41 · 805 filings